ArticleBreast cancer (Dove Medical Press)2025
Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets.
Hua-Hsin Hsiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.